The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
13160
Product Theater: Taking a Deep Dive Into Eohilia, an Oral Therapeutic Option
Date
May 5, 2025
Society: DDW
Join our discussion as we look at answering an unmet need in pediatric and adult patients with Eosinophilic Esophagitis (EoE) through an oral therapeutic option, EOHILIA (budesonide oral suspension). EOHILIA is a ready-to-use oral suspension that was designed specifically for EoE.
Supported by: Takeda Pharmaceuticals U.S.A., Inc.
